Hibiocy

Hibiocy is a private company based in Bangkok, Thailand, and a subsidiary of Rojukiss International Public Company Limited (KISS), Thailand's leading beauty and health company. Hibiocy has developed COVITRAP™, a nasal spray product containing anti-COVID antibody medication. COVITRAP™ prevents the COVID-19 virus from attaching to the inner surface of the nasal cavity, thereby reducing the viral load within the cavity. Currently, Hibiocy is working on launching the COVITRAP™ nasal spray in other countries.